The Augustinus Foundation, Denmark.   Report issue

Foundation Phase 2
Founded: Copenhagen Denmark (1942)

Organization Overview

First Clinical Trial
2006
NCT00328796
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

The Augustinus Foundation, Denmark.

Active Ingredients

Drugs in Phase 2 Trials (1)

epoetin (Epogen) (1 trial)

Drugs in Other Trials (2)

4-aminopyridine (1 trial)

lidocaine (xylocaine) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Bipolar Disorder (Phase 2)

Cognitive Dysfunction (Phase 2)

Depression (Phase 2)

Depressive Disorder (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 3
  • # of Trial APIs: 3